Clinical Trial: Personalized Dietary Feedback to Reduce Hepatic Steatosis in Patients With MASLD

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07914829) titled 'Personalized Dietary Feedback to Reduce Hepatic Steatosis in Patients With MASLD' on Oct. 20.

Brief Summary: Metabolic dysfunction-associated steatotic liver disease (MASLD) and combined metabolic dysfunction and alcohol-associated liver disease (MetALD) are common chronic liver diseases associated with metabolic dysfunction and an increased risk of liver-related and cardiovascular complications. Lifestyle modification, particularly dietary changes and increased physical activity, represents a cornerstone of treatment. However, general lifestyle recommendations are often insufficient to achieve sustained improvements.

This prospecti...